Silva Pharmaceuticals Limited (DSE: SILVAPHL)
Health Care · Pharmaceuticals · BD
Tk15.10
-6.79% today · +30.2% 1Y
Silva Pharmaceuticals Limited (DSE: SILVAPHL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $16.85M.
Over the last twelve months the share price has gained 30.2%, trading between 7.60 and 18.00.
Tweenvest scores Silva Pharmaceuticals Limited across four factors: quality 63/100, value 49/100, growth 0/100. Its strongest factor is quality.
SILVAPHL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.85M
- Revenue (TTM)
- $2.69M
- P/E
- —
- EPS
- -1.13
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- Tk18.00
- 52-week low
- Tk7.60
- Avg volume (3M)
- —
- Shares outstanding
- 136.50M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,257.82 | +0.87% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $153.92 | +2.16% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.60 | +0.86% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £123.85 | +2.27% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.35 | +1.34% |
Figures last refreshed Aug 18, 2026.